The Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas, Inc (NAPPSA) has appointed Pharmacist Ahmed Ibrahim Yakasai, as a board member.
Yakasai, the immediate past president of the Pharmaceutical Society of Nigeria (PSN), is joining the board of NAPPSA, an umbrella organization of Nigerian pharmacists, pharmaceutical scientists, allied scientists and the academia in the Americas.
Yakasai’s appointment was based on NAPPSA board’s recommendation on the 10th of March 2019, where he was confirmed as a board member for a 4-year single term.
Yakasai is an accomplished pharmacist/independent consultant with comprehensive background in the pharmaceutical field and international marketing with bias in research and social media marketing.
He has a long distinguished career in various fields of pharmacy, healthcare and research/regulatory affairs. He is the immediate past president of the Pharmaceutical Society of Nigeria (PSN) 2015-2018.
He is also an Honorary Consul-General of Pakistan in Nigeria and Founder/Chairman, Safe Medicines Foundation.
He is a Fellow of Pharmaceutical Society of Nigeria, Fellow of Institute of Logistics Management of Nigeria, Fellow of Chartered Institute of Commerce, Fellow of Nigeria Academy of Pharmacy, Fellow of West African Postgraduate College of Pharmacists and Fellow of Nigerian Institute of Management.
He obtained his first degree in Pharmacy from the prestigious Ahmadu Bello University, Zaria (1983) and Postgraduate of International Marketing (search and social media marketing- 2014/2015 from University of Salford, Manchester, UK and attended many other courses.
Ahmed was a two-term commissioner in Kano State – Commerce, Industry, Cooperatives and Tourism (2005-2010) and Ministry of Land and Physical Planning (2010-2011). He joined the private sector in 1987.
He has earned enviable honours from many organizations.
NAPPSA has among its objectives “to promote healthy living and disease prevention through effective pharmaceutical care and facilitation of efficient healthcare delivery systems and strategies in America, Nigeria, Africa and the rest of the world.”